Diabetes, use of metformin, and the risk of meningioma

BACKGROUND: Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. METHODS: We conducted a matched case-control analysis using data from the U....

Descripción completa

Detalles Bibliográficos
Autores principales: Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S., Proescholdt, Martin, Bogdahn, Ulrich, Hau, Peter, Leitzmann, Michael F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510861/
https://www.ncbi.nlm.nih.gov/pubmed/28708856
http://dx.doi.org/10.1371/journal.pone.0181089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510861/
https://www.ncbi.nlm.nih.gov/pubmed/28708856
http://dx.doi.org/10.1371/journal.pone.0181089

Ejemplares similares